Cargando…

Correction: A Novel Approach to Delayed-Start Analyses for Demonstrating Disease-Modifying Effects in Alzheimer’s Disease

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476809/ https://www.ncbi.nlm.nih.gov/pubmed/26098864 http://dx.doi.org/10.1371/journal.pone.0131338

Ejemplares similares

A Novel Approach to Delayed-Start Analyses for Demonstrating Disease-Modifying Effects in Alzheimer’s Disease
por: Liu-Seifert, Hong, et al.
Publicado: (2015)

Delayed-start analysis for demonstrating disease modification of solanezumab
por: Wolters, Frank J., et al.
Publicado: (2015)

Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease
por: Ritchie, Craig W., et al.
Publicado: (2018)

Correction to: New approaches to symptomatic treatments for Alzheimer’s disease
por: Cummings, Jeffrey
Publicado: (2021)

Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease
por: Ray, Balmiki, et al.
Publicado: (2020)

Correction to: Knock-on effect of periodontitis to the pathogenesis of Alzheimer’s disease?
por: Leblhuber, Friedrich, et al.
Publicado: (2020)

Correction: A Modified Method for Whole Exome Resequencing from Minimal Amounts of Starting DNA
por: Kozarewa, Iwanka, et al.
Publicado: (2012)

Correction: Predicting progression of Alzheimer's disease
por: Doody, Rachelle S, et al.
Publicado: (2010)

Correction to: Complement in the pathogenesis of Alzheimer’s disease
por: Paul Morgan, B.
Publicado: (2018)

Correction to: Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
por: Bai, Bing, et al.
Publicado: (2021)

Correction: Curcumin and Apigenin – novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease
Publicado: (2015)

Correction: The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
por: Craddock, Travis J. A., et al.
Publicado: (2012)

Correction: The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
por: Craddock, Travis J. A., et al.
Publicado: (2012)

Correction: The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
por: Craddock, Travis J. A., et al.
Publicado: (2013)

Correction: GWAS on family history of Alzheimer’s disease
por: Marioni, Riccardo E., et al.
Publicado: (2019)

Correction: A Robust and Efficient Production and Purification Procedure of Recombinant Alzheimers Disease Methionine-Modified Amyloid-β Peptides
por: Hoarau, Marie, et al.
Publicado: (2018)

Correction: A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease
Publicado: (2014)

Correction: Effects of Huanglian-Jie-Du-Tang and Its Modified Formula on the Modulation of Amyloid-β Precursor Protein Processing in Alzheimer's Disease Models
Publicado: (2014)

Correction to: A Novel Stable Isotope Approach Demonstrates Surprising Degree of Age-Related Decline in Skeletal Muscle Collagen Proteostasis
Publicado: (2022)

Correction to: Peripheral immune system in aging and Alzheimer’s disease
por: Cao, Wei, et al.
Publicado: (2018)

Correction to: Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration
Publicado: (2023)

Correction: A Physically-Modified Saline Suppresses Neuronal Apoptosis, Attenuates Tau Phosphorylation and Protects Memory in an Animal Model of Alzheimer's Disease
por: Modi, Khushbu K., et al.
Publicado: (2017)

Author Correction: Comparative profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation
por: Castillo, Erika, et al.
Publicado: (2021)

Correction: How Statins May Protect against Alzheimer Disease
Publicado: (2012)

Correction: Single-Subject Grey Matter Graphs in Alzheimer's Disease
por: Tijms, Betty M., et al.
Publicado: (2013)

Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2023)

Correction: Vector mapping and bloodmeal metabarcoding demonstrate risk of urban Chagas disease transmission in Caracas, Venezuela
por: Segovia, Maikell, et al.
Publicado: (2023)

Publisher Correction: Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
por: Flores, Joseph, et al.
Publicado: (2021)

Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
por: Femminella, Grazia Daniela, et al.
Publicado: (2020)

Correction: APOE4-mediated Alzheimer disease and “Vascular”—“Meningeal Lymphatic” components: towards a novel therapeutic era?
por: Chen, Zhangying, et al.
Publicado: (2021)

Correction to: Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
por: Boza-Serrano, Antonio, et al.
Publicado: (2023)

Correction: Aberrant iPSC-derived human astrocytes in Alzheimer’s disease
por: Jones, V. C., et al.
Publicado: (2019)

Correction to: Probability of Alzheimer’s disease based on common and rare genetic variants
por: Escott-Price, Valentina, et al.
Publicado: (2021)

Correction: Parp mutations protect from mitochondrial toxicity in Alzheimer’s disease
por: Yu, Yizhou, et al.
Publicado: (2021)

Correction to: Whole exome sequencing identifies novel candidate genes that modify chronic obstructive pulmonary disease susceptibility
por: Bruse, Shannon, et al.
Publicado: (2021)

Correction to: Deleterious effects of dialysis emergency start, insights from the French REIN registry
por: Michel, Alain, et al.
Publicado: (2018)

Author Correction: Predicting Alzheimer’s disease progression using multi-modal deep learning approach
por: Lee, Garam, et al.
Publicado: (2023)

Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
por: Sandebring, Anna, et al.
Publicado: (2013)

Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
por: Sandebring, Anna, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m0all2nffb5kg8ipo2sto3rbi3